A Chinese group identified that exosomal miR-9 derived from nasopharyngeal carcinoma cells inhibits angiogenesis by targeting Midkine (a heparin-binding growth factor) and regulating the PDK/AKT pathway in nasopharyngeal carcinoma [203]. The gene discussed is MDK; the disease is nasopharyngeal carcinoma.